1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. ...
Click here to read this study in NEJM
1. Amongst a cohort of individuals with arterial hypertension, those who were taking angiotensin receptor blocker antihypertensives had the lowest ...
1. Compared to control, ARBs reduced the annual rate of increase of the aortic root Z score by approximately one-half. ...
1. In patients with acute myocardial infarction, Sacubitril-valsartan was not associated with a significantly lower incidence of death from cardiovascular ...
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
1. Amongst the five examined classes of antihypertensive medications (ACE Inhibitors, ARBs, beta blockers, calcium-channel blockers, and thiazide diuretics), none ...
1. Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) were not shown to affect the risk of coronavirus disease 2019 (Covid-19). ...
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial 1. Adults with severe COVID-19 treated with remdesivir ...
